by Jim Lynch, University of Michigan Dr. Alex Duryea, Ph.D., Manager of Applied Research at HistoSonics, adjusts an ultrasound “phantom”—a gel mixed with red blood cells that serves as the test’s tumor—prior to performing a histotripsy treatment demonstration. Credit: Erica Bass, Rogel Cancer Center, Michigan MedicineThe U.S. Food and Drug Administration has approved the use of...
